Literature DB >> 27572636

Possible tumor suppressive role of the miR-144/451 cluster in esophageal carcinoma as determined by principal component regression analysis.

Zhikui Gao1, Ran Liu1, Juan Liao1, Miao Yang1, Enchun Pan2, Lihong Yin1, Yuepu Pu1.   

Abstract

MicroRNA (miRNA) clusters are expressed universally across different types of organisms, and an accumulating number of studies have demonstrated that miRNA clusters function more efficiently compared with single miRNAs during the development of certain cancer types. miRNA clusters may have increased stability and reliability over individual miRNAs as diagnostic or therapeutic biomarkers. In the present study, the expression levels of mature miRNAs within the miR-144/451 cluster were examined using stem‑loop reverse transcription‑quantitative polymerase chain reaction in 102 patients pathologically diagnosed with esophageal carcinoma. Bioinformatics tools were used to identify a possible miRNA‑mediated network of the miR‑144/451 cluster. The expression levels of hsa‑miR‑451a, hsa‑miR‑144‑3p and hsa‑miR‑144‑5p in tumor tissues were significantly lower compared with those in adjacent non‑tumor tissues (P<0.05). Pearson correlation analysis demonstrated that the expression levels of individual miR‑144/451 cluster members were correlated with each other, except for the pair of hsa‑miR‑144‑3p and hsa‑miR‑4732‑3p. In particular, hsa‑miR‑144‑5p expression was highly associated with hsa-miR-4732‑5p and hsa-miR-451a expression levels, with correlation coefficients of 0.729 and 0.608, respectively. Furthermore, the low expression levels of hsa‑miR‑144‑3p [odds ratio (OR), 0.85; P<0.05] and hsa-miR-144-5p (OR, 0.84; P<0.05) were determined to be risk factors for esophageal carcinoma development. Kyoto Encyclopedia of Genes and Genomes pathway analysis demonstrated that miRNAs forming the miR‑144/451 cluster may cooperate to regulate the cell cycle. Therefore, the miR‑144/451 cluster may serve an important role in the progression of esophageal carcinoma and may be considered as a biomarker for the detection of esophageal carcinoma at an early stage.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27572636     DOI: 10.3892/mmr.2016.5691

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  19 in total

1.  Identification of down-regulated microRNAs in thyroid cancer and their potential functions.

Authors:  Denghua Pan; Peng Lin; Dongyue Wen; Yunpeng Wei; Qiuyan Mo; Liang Liang; Gang Chen; Yun He; Junqiang Chen; Hong Yang
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

2.  Bone marrow mesenchymal stem cell-derived exosomal miR-144-5p improves rat ovarian function after chemotherapy-induced ovarian failure by targeting PTEN.

Authors:  Meiling Yang; Li Lin; Chunli Sha; Taoqiong Li; Dan Zhao; Hong Wei; Qi Chen; Yueqin Liu; Xiaofang Chen; Wenlin Xu; Yuefeng Li; Xiaolan Zhu
Journal:  Lab Invest       Date:  2019-09-19       Impact factor: 5.662

3.  miRNA Profiling of Major Testicular Germ Cells Identifies Stage-Specific Regulators of Spermatogenesis.

Authors:  Shruti Sethi; Poonam Mehta; Aastha Pandey; Gopal Gupta; Singh Rajender
Journal:  Reprod Sci       Date:  2022-06-17       Impact factor: 3.060

4.  Ultrasound-targeted microbubble destruction-mediated miR-144-5p overexpression enhances the anti-tumor effect of paclitaxel on thyroid carcinoma by targeting STON2.

Authors:  Xuefeng Chen; Xinyuan Zhang; Yangyang Qian; Enhui Xia; Yu Wang; Qi Zhou
Journal:  Cell Cycle       Date:  2022-02-20       Impact factor: 5.173

5.  miR-144 inhibits the IGF1R-ERK1/2 signaling pathway via NUDCD1 to suppress the proliferation and metastasis of colorectal cancer cells: a study based on bioinformatics and in vitro and in vivo verification.

Authors:  Bin Han; Ke Xu; Dan Feng; Yang Bai; Yangqi Liu; Yuanyuan Zhang; Liming Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2022-04-27       Impact factor: 4.322

Review 6.  Non-coding RNAs: new biomarkers and therapeutic targets for esophageal cancer.

Authors:  Xiaobin Hou; Jiaxin Wen; Zhipeng Ren; Guoliang Zhang
Journal:  Oncotarget       Date:  2017-06-27

7.  A comprehensive insight into the clinicopathologic significance of miR-144-3p in hepatocellular carcinoma.

Authors:  Hai-Wei Liang; Zhi-Hua Ye; Shu-Ya Yin; Wei-Jia Mo; Han-Lin Wang; Jin-Che Zhao; Guo-Mei Liang; Zhen-Bo Feng; Gang Chen; Dian-Zhong Luo
Journal:  Onco Targets Ther       Date:  2017-07-11       Impact factor: 4.147

8.  miR-144-5p Enhances the Radiosensitivity of Non-Small-Cell Lung Cancer Cells via Targeting ATF2.

Authors:  Lei Song; Liping Peng; Shucheng Hua; Xiaoping Li; Lianjun Ma; Jing Jie; Dong Chen; Ying Wang; Dan Li
Journal:  Biomed Res Int       Date:  2018-04-12       Impact factor: 3.411

9.  miR-144/451 cluster plays an oncogenic role in esophageal cancer by inhibiting cell invasion.

Authors:  Zhikui Gao; Peng Zhang; Ming Xie; Han Gao; Lihong Yin; Ran Liu
Journal:  Cancer Cell Int       Date:  2018-11-15       Impact factor: 5.722

10.  Impact of novel oncogenic pathways regulated by antitumor miR-451a in renal cell carcinoma.

Authors:  Yasutaka Yamada; Takayuki Arai; Sho Sugawara; Atsushi Okato; Mayuko Kato; Satoko Kojima; Kazuto Yamazaki; Yukio Naya; Tomohiko Ichikawa; Naohiko Seki
Journal:  Cancer Sci       Date:  2018-03-09       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.